Neoleukin: 3Q Earnings Snapshot

November 13, 2019 GMT

VANCOUVER, British Columbia (AP) _ Neoleukin Therapeutics, Inc. (NLTX) on Wednesday reported a loss of $59.1 million in its third quarter.

The Vancouver, British Columbia-based company said it had a loss of $2.26 per share. Losses, adjusted for non-recurring costs, were 44 cents per share.

The company’s shares closed at $2.98. A year ago, they were trading at $2.26.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NLTX at https://www.zacks.com/ap/NLTX